Comparison of the histological changes in the skin of DBA/2 and C57BL/6 mice following exposure to various promoting agents

Carcinogenesis

Volumn 8, Issue 12, 1987, Pages 1807-1815

  Naito, Masashi ^a   Naito, Yukiko ^a   Digiovanni, John ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRYSAROBIN; MEZEREIN; TUMOR PROMOTER;

ANIMAL EXPERIMENT; COMPARATIVE STUDY; HISTOLOGY; HISTOPATHOLOGY; MOUSE; NONHUMAN; SKIN CARCINOGENESIS;

ANIMAL; ANTHRACENES; BENZO(A)PYRENE; CARCINOGENS; COMPARATIVE STUDY; LYNGBYA TOXINS; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; SKIN; SKIN NEOPLASMS; SPECIES SPECIFICITY; SUPPORT, U.S. GOV'T, P.H.S.; TERPENES; TETRADECANOYLPHORBOL ACETATE;

EID: 0023626472     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/8.12.1807     Document Type: Article

References (39)

1. Boutwell, R.K. (1964) Some biological aspects of sirin carcinogenesis. Prog. Exp. Tumor Res., 4, 207-250.
2. Slaga, T.J. (1983) Overview of tumor promotion in animals. Environ. Health Perspea., 50, 3 14.
3. DiGiovanni, I., Slaga, T.J. and Boutwell, R.K. (1980) Comparison of the tumor-initiating activity of 7,12-dimethylbenz(a]anthracene and benzo(a]pyrene in female SENCAR and CD-I mice. Carcinogenesis, 1, 381-389.
4. Ashman, L.K., Murray, A.W., Cook, M.G. and Kotiarslri, I. (1982) Two-stage skin carcinogenesis in sensitive and resistant mouse strains. Carcinogenesis, 3, 99-102.
5. Hennings, H., Devor, D., Wenk, M.L., Slaga, T.J., Former, B., Colburn, N.H., Bowden, G.T., Elgjo, K. and Yuspa, S.H. (1981) Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a]anthracene or N-methyl-A/’-nitro-A'-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Cancer Res., 41, 773-779.
6. Reiners J. J., Jr. N Esnow, S. and Slaga, T.J. (1984) Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion. Carcinogenesis, 5, 301-307.
7. DiGiovanni J., Naito, M. and Chenicek, K.J. (1987) Genetic factors controlling susceptibility to skin tumor promotion in mice. In Barret, C J., Langenbach, E. and Gilmore, E. (eds), Tumor Promoters: Biological Approaches for Mechanistic Studies and Assay Systems. Raven Press, New York, in press.
8. DiGiovanni J., Prichett, W.P., Decina, P.C. and Diamond, L. (1984) DBA/2 mice are as sensitive as SENCAR mice to skin tumor promotion by 12-0-tetradecanoylphorbol-13-acetate. Carcinogenesis, 5, 1493-1498.
9. Klein-Szanto, A. J. P. (1984) Morphological evaluation of tumor promoter effects on mammalian skin. In Slaga, T.J. (ed.), Mechanisms of Tumor Promotion, V.Ol. 2, Tumor Promotion and Skin Carcinogenesis. CRC Press, Boca Raton, F.L.pp. 4172.
10. Sisskin, E.E., Gray, T. and Barrett J. C. (1982) Correlation between sensitivity to tumor promotion and sustained epidermal hyperplasia of mice and rats treated with 12-0-tetradecanoylphorbol-13-acetate. Carcinogenesis, 3, 403-407.
11. Lewis J. G. and Adams, D.O. (1986) Correlation between inflammation in skin, the release of HjOj by macrophages (M), and sensitivity to the promotion of skin tumors by phorbol esters (PE). Proc. Am. Assoc. Cancer Res., 27, 146.
12. Lewis, G. and Adams, D.O. (1986) Enhanced release of hydrogen peroxide and metabolites of arachidonic acid by macrophages from SENCAR mice following stimulation with phorbol esters. Cancer Res., 46, 5696-5700.
13. Fischer, S.J., Baldwin, K. and Adams, L.M. (1986) Effects of anli-ptomoters and strain of mouse on tumor promoter-induced oxidants in murine epidermal cells. Carcinogenesis, 7, 915-918.
14. DiGiovanni J. and Boutwell, R.K. (1983) Tumor promoting activity of 1,8-dihydroxy-3-methyl-9-anthrone (chrysarobin) in female SENCAR mice. Carcinogenesis, 4, 281-284.
15. Kruszewski, F.H., Conti, C.I. and DiGiovanni J. (1987) Characterization of skin tumor promotion and progression by chrysarobin. Cancer Res., 47, 3783-3790.
16. Klein-Szanto A. L. P., Major, S.K. and Slaga, T. L. (1980) Induction of dark keratinocytes by 12-0-tetradecanoylphorbol-13-acetate and mezerein as an indicator of tumor-promoting efficiency. Carcinogenesis, 1, 399-406.
17. Fujild, H., Mori, M., Nakayasu, M., Terada, M., Sugjmura, T. and Moore, R.E. (1981) Indole alkaloids: dihydroteleocidin B, teleocidin and lyngbyatoxin A as members of a new class of tumor promoters. Proc. NatL Acad. Sci. USA, 78, 3872-3876.
18. Fujiki, H., Suganuma, M., Malsukura, N., Sugimura, T. and Takayama, S. (1982) Teleocidin from Streptomyces is a potent promoter of mouse carcinogenesis. Carcinogenesis, 3, 895-898.
19. Horowitz, A. D., Fujiki, H., Weinstein, I.B., Jeffrey, A., Oldn, E., Moore, R.E. and Sugimura, T. (1983) Comparative effects of aplysiatoxin, debromoaplysia-toxin and teleocidin on receptor binding and phospholipid metabolism. Cancer Res., 43, 1529-1535.
20. Diamond, L., O’Brien, T.G. and Baird, W.M. (1980) Tumor promoters and the mechanism of tumor promotion. Adv. Cancer Res., 32, 1-74.
21. Blumbetg, P.M., Durm J. A., laken, S., Jeng, A.Y., Leach, K.L., Shatkey, N.A. and Yeh, E. (1984) Specific receptors for phorbol ester tumor promoters and their involvement in biological responses. In Slaga, T.l. (ed.), Mechanisms of Tumor Promotion, VoL III, Tumor Promotion and Carcinogenesis In Vitro. CRC Press, Boca Raton, F.L.pp. 143-184.
22. Coussens, L., Parker, P., Rhee, L., Yang-Feng, T.L., Chen, E., Water-field, M.D., Franchke, V. and Ulrich, A. (1986) Multiple distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science, 233, 859 866.
23. Huang, K.P., Nakabayashi, H. and Huang, F.L. (1986) Isozymk forms of rat brain Ca2+-activated and phospholipid-dependent protein kinase. Proc. NatL Acad. Sci. USA, 83, 8535-8539.
24. Kruszewsld, F.H., Chenicek, K J. and DiGiovanniJ. (1986) Effect of application frequency cur epidermal ornithine decarboxylase induction by chrysarobin in SENCAR mice. Cancer Lett., 32, 263-269.
25. DiGiovanni J., Kruszewski, F.H. and Chenicek, K.J. (1987) Studies on the skin tumor promoting actions of chrysarobin (l,8-dihydroxy-3-methyl-9-an-throne). In Butterworth, B. and Slaga, T.l. (eds), Nongenotoxic Mechanisms of Carcinogenesis. Cold Spring Harbor Press, New York, Banbury Report 25, in press.
26. Boutwell, R.K. (1974) The function and mechanisms of promoters of carcinogenesis. Crit. Rev. ToxicoL, 2, 419-443.
27. Scribner J. D. and Suss, T. (1978) Tumor initiation and promotion. Int. Rev. Exp. Pathol., 18, 137-198.
28. Argyris, T.S. (1983) An analysis of the epidermal hyperplasia produced by acetic acid, a poor promoter in the skin of female mice initited with demethyl-benzanthracene. J. Invest. Dermatol, 80, 430-435.
29. Argyris, T.S. (1983) Nature of epidermal hyperplasia produced by mezerein, a weak tumor promoter, in initiated skin of mice. Cancer Res., 43, 1768-1773.
30. Hennings, H., Shores, R., Mitchell, P., Spangler, E.F. and Yuspa, S.H. (1985) Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis, 6, 1607 1610.
31. Klein-Szanlo A. J. P. and Slaga, T. J. (1982) Effect of peroxides on rodent skin: epidermal hyperplasia and tumor promotion. J. Invest. Dermatol, 79, 3034.
32. Raick, A.N. and Burdzy, K. (1973) Ultrastructural and biochemical changes induced in mouse epidermis by a hyperplastic agent, e.thylphenylpropriolate. Cancer Res., 33, 2221-2230.
33. Raick, A.N. (1974) Cell differentiation and tumor-promoting action in skin carcinogenesis. Cancer Res., 34, 2915-2925.
34. Klein-Szanto A. J. P. and Slaga, T. L. (1981) Numerical variation of dark cells in normal and chemically induced hyperplastic epidermis with age of animal and efficiency of tumor promoter. Cancer Res., 41, 4437-4440.
35. Chiba, M., Slaga, T.J. and Klein-Szanto A. I. P. (1984) A morphometric study of dedifferentiated and involutional dark keratinocytes in 12-O-tetradecanoyl-phorbol-13-acetate-treated epidermis. Cancer Res., 44, 2711-2717.
36. Murakami, Y., Hibino, T., Arai, M. and Kurolri, T. (1985) Appearance of dark keratinocytes following intracutaneous injection of cholera toxin in mouse skin. J. Invest. Dermatol, 85, 115-117.
37. Glaso, M., Ree J. C., Inversen, O.H. and Hovig, T. (1986) The influence of different fixatives and a tumor promoter, 12-O-tetradecanoylphortiol-13-acetate (TPA), on the induction of so-called dark cells in mouse epidermis. Virchow's Arch. Cell Pathol., 50, 355-372.
38. Aldaz, C.M., Conti, C.J., Gimenez, I.B., Slaga, T.J. and Klein-Szanto A. L. P. (1985) Cutaneous changes during prolonged application of 12-O-tetradecanoyl-phorbol-13-acetate on mouse skin and residual effects after cessation of treatment. Cancer Res., 45, 2753-2759.
39. Lewis J. G. and Adams, D. O. (1987) Early inflammatory changes in the skin of SENCAR and C57BL/6 mice following exposure to 12-O-tetradecanoyl-phorbol-13-acetate. Carcinogenesis, 8, 889-898.